Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	1.66	5.24	7.36	27.59	8.76
Cash & Short-Term Investments	1.66	5.24	7.36	27.59	8.76
Cash Growth	-68.38%	-28.80%	-73.32%	214.77%	61.28%
Accounts Receivable	-	0	-	-	0
Other Receivables	0.13	0.1	0.05	0.08	1.19
Receivables	0.13	0.11	0.05	0.08	1.19
Prepaid Expenses	0.59	1.63	2	1.72	0.54
Other Current Assets	3.76	3.79	0.04	0.01	0.16
Total Current Assets	6.15	10.77	9.45	29.39	10.65
Other Intangible Assets	15.4	17.27	19.14	22	12.41
Other Long-Term Assets	0.04	0.04	7.3	6.69	-
Total Assets	21.59	28.08	35.89	58.09	23.06
Accounts Payable	4.55	0.86	1.52	1.89	1.69
Accrued Expenses	10.88	4.16	2.6	3.27	1.99
Short-Term Debt	0.63	1.8	1.84	-	-
Other Current Liabilities	9.73	0.75	0.76	3.16	1.39
Total Current Liabilities	25.8	7.57	6.73	8.33	5.07
Long-Term Deferred Tax Liabilities	2.02	2.29	2.56	2.93	3.41
Other Long-Term Liabilities	3.75	6.12	8.21	8.93	0.46
Total Liabilities	31.6	16.03	17.61	20.24	8.94
Common Stock	101.64	97.45	84.48	80.29	48.78
Retained Earnings	-115.13	-89.08	-68.62	-44.2	-36.19
Comprehensive Income & Other	3.48	3.68	2.41	1.76	1.53
Total Common Equity	-10.02	12.05	18.27	37.85	14.13
Shareholders' Equity	-10.02	12.05	18.27	37.85	14.13
Total Liabilities & Equity	21.59	28.08	35.89	58.09	23.06
Total Debt	0.63	1.8	1.84	-	-
Net Cash (Debt)	1.02	3.45	5.52	27.59	8.76
Net Cash Growth	-70.30%	-37.59%	-79.99%	214.77%	61.28%
Net Cash Per Share	0.39	1.87	4.17	23.44	12.00
Filing Date Shares Outstanding	4.35	2.36	1.5	1.32	0.95
Total Common Shares Outstanding	3.33	2.28	1.39	1.32	0.95
Working Capital	-19.65	3.21	2.72	21.06	5.59
Book Value Per Share	-3.01	5.28	13.17	28.67	14.93
Tangible Book Value	-25.42	-5.22	-0.86	15.85	1.72
Tangible Book Value Per Share	-7.64	-2.29	-0.62	12.01	1.81

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q